AssetMark Inc’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12K Buy
110
+7
+7% +$667 ﹤0.01% 2249
2025
Q4
$8.35K Buy
103
+9
+10% +$775 ﹤0.01% 2282
2025
Q3
$8.23K Buy
94
+52
+124% +$4.64K ﹤0.01% 2179
2025
Q2
$3.49K Buy
+42
New +$3.51K ﹤0.01% 2248
2018
Q1
Sell
-4
Closed 1721
2017
Q4
$0 Buy
+4
New +$137 ﹤0.01% 2008

Other funds holding LMAT

AssetMark Inc's LMAT Position: Q1 2026 in Review

AssetMark Inc increased its LeMaitre Vascular (LMAT) stake by 6.8% in Q1 2026, buying an estimated $667 and bringing the position to 110 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

AssetMark Inc first reported a position in LMAT in Q4 2017 and has held it in 5 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • AssetMark Inc held 110 shares of LeMaitre Vascular worth $12K as of Q1 2026.
  • AssetMark Inc bought 7 LeMaitre Vascular shares in Q1 2026, an estimated $667.
  • LeMaitre Vascular made up ﹤0.01% of AssetMark Inc's portfolio in Q1 2026, its #2249 holding.
  • AssetMark Inc first reported a position in LeMaitre Vascular in Q4 2017 and has held it in 5 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.